TMIV Imaging launches CLARION 64/128-Slice AI-driven CT System at India Health Expo 2026: Our Bureau, Mumbai Tuesday, September 1, 2026, 17:20 Hrs [IST] Time Medical International ...
Yashoda Medicity signs MoU with Republic of Kazakhstan, Turkistan City: Our Bureau, Mumbai Tuesday, September 1, 2026, 12:30 Hrs [IST] Yashoda Medicity, a leading healthcare insti ...
Donald Trump announces deal with nine additional pharma manufacturers to lower drug prices for Americans: Our Bureau, Mumbai Tuesday, September 1, 2026, 17:10 Hrs [IST] President ...
Thrive, a functional medicine company, has unveiled its new white paper titled “Magnesium in Motion: A Dynamic Study of Supplement Absorption", providing in-depth insights about the significance of ...
Amgen's Repatha reduces risk of death in patients at high risk for a first heart attack or stroke: Thousand Oaks, California Tuesday, September 1, 2026, 18:00 Hrs [IST] Amgen anno ...
Bayer presents detailed results from phase III REVEAL study with investigational PET radiotracer iodine 124 evuzamitide at ESC 2026: Berlin, Germany Tuesday, September 1, 2026, 16 ...
RedHill divests Talicia business to Apotex for $18 million cash upfront plus milestones to fuel strategic growth opportunities: Raleigh, North Carolina Tuesday, September 1, 2026, ...
India continues to face a significant burden of corneal blindness, with donor cornea availability falling well short of the need. While the eye-banking ecosystem has strengthened, greater public ...
Compassionate Patient Response to host India Health Forward 2047 summit in Hyderabad on Sept 12: Our Bureau, Mumbai Tuesday, September 1, 2026, 13:00 Hrs [IST] Compassionate Patie ...
Sun Pharma joins White House agreement to expand affordable medicines in US: Our Bureau, Mumbai Tuesday, September 1, 2026, 12:20 Hrs [IST] Sun Pharmaceutical Industries Limited j ...
Bayer presents positive results from a pre-specified subgroup analysis of the phase III FIND-CKD trial at ESC Congress 2026 in Munich, Germany: Berlin Tuesday, September 1, 2026, ...
Karyopharm Therapeuticsseeks US FDA’s accelerated approval for Xpovio plus ruxolitinib for patients with myelofibrosis: Newton, Massachusetts Tuesday, September 1, 2026, 17:00 H ...